India Gammachim Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 28-06-2024
- Paid Up Capital ₹ 1.00 M
as on 28-06-2024
- Company Age 33 Year, 10 Months
- Last Filing with ROC 31 Mar 2018
- Revenue %
(FY 2018)
- Profit 53.89%
(FY 2018)
- Ebitda 53.89%
(FY 2018)
- Net Worth -0.78%
(FY 2018)
- Total Assets -3.17%
(FY 2018)
About India Gammachim
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Bela Rastogi, Akshat Rastogi, and Umesh Rastogi serve as directors at the Company.
- CIN/LLPIN
U99999MH1991PLC059974
- Company No.
059974
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Jan 1991
- Date of AGM
29 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at India Gammachim?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bela Rastogi  | Director | 19-Feb-2014 | Current |
| Akshat Rastogi | Director | 19-Feb-2014 | Current |
| Umesh Rastogi | Director | 19-Feb-2014 | Current |
Financial Performance of India Gammachim.
India Gammachim Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 53.89% increase in profit. The company's net worth dipped by a decrease of 0.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of India Gammachim?
In 2018, India Gammachim had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Thomas Baker (Chemicals) Private LimitedActive 44 years 1 monthBela Rastogi and Umesh Rastogi are mutual person
- Thomas Baker (Biosciences) Private LimitedActive 36 years 6 months
Bela Rastogi and Umesh Rastogi are mutual person
Chemstreet Impex LlpActive 7 years 5 monthsBela Rastogi, Akshat Rastogi and 1 more are mutual person
- Baker Realty Corporation LlpActive 3 years 2 months
Akshat Rastogi and Umesh Rastogi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at India Gammachim?
Unlock and access historical data on people associated with India Gammachim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of India Gammachim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped India Gammachim's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
